During a briefing in the government on issues related to the start of mass vaccination against coronavirus in Russia, Golikova said that the vaccine of the Chumakov Center "KoviVac" is "an inactivated whole-virion purified concentrated vaccine", which is administered twice with an interval of 14 days and is stored at a temperature of +2 ... + 8 ° C.
“The data from clinical studies have confirmed the complete safety and low reactogenicity of this vaccine.
The majority of the subjects showed the formation of stable immunity already on the 28th day after the first vaccination, ”she stressed.
Earlier it was reported that the vaccine from the Chumakov Center could go into civilian circulation in March.
On October 6, the Chumakov Center began clinical trials of its own vaccine against coronavirus.